Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 57 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 7658923

    Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26

    The Board of Regents of the University of Texas System · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted
  2. US 7655241

    Methods and compositions for vaccination against or involving enterobacteriaceae bacteria

    The Board of Regents of the University of Texas System · Granted Feb 2, 2010 · Expires Jan 28, 2030

    granted
  3. US 7645732

    Treating hepatitis C virus infection

    The Board of Regents of the University of Texas System · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted
  4. US 7642234

    Beta-2-glycoprotein 1 is an inhibitor of angiogenesis

    The Board of Regents of the University of Texas System · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted
  5. US 7638284

    Immunoglobulin A inducing protein and uses therefor

    The Board of Regents of the University of Texas · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted
  6. US 7638544

    Dimeric small molecule potentiators of apoptosis

    The Board of Regents of the University of Texas System · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted
  7. US 7638135

    Collagen-binding proteins from enterococcal bacteria

    The Board of Regents of the University of Texas System · Granted Dec 29, 2009 · Expires Dec 24, 2029

    granted
  8. US 7632502

    Cell wall mannoproteins and active epitopes from Candida albicans and antibodies recognizing them

    The Board of Regents of the University of Texas System · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted
  9. US 7632484

    Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Dec 15, 2009 · Expires Dec 10, 2029

    granted
  10. US 7627938

    Tapered hollow metallic microneedle array assembly and method of making and using the same

    The Board of Regents of the University of Texas System · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted
  11. US 7629308

    Methods relating to muscle selective calcineurin interacting protein (MCIP)

    The Board of Regents of the University of Texas System · Granted Dec 8, 2009 · Expires Dec 3, 2029

    granted
  12. US 7625563

    Cancer treatment methods using selected immunoconjugates for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Dec 1, 2009 · Expires Nov 26, 2029

    granted
  13. US 7622118

    Cancer treatment methods using selected antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted
  14. US 7619000

    S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer

    The Board of Regents of the University of Texas System · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  15. US 7618630

    Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists

    The Board of Regents of the University of Texas System · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  16. US 7615208

    Metal ion-labeled bis-aminoethanethiol-targeting ligand conjugates, compositions, and methods for tissue-specific disease imaging

    The Board of Regents of the University of Texas System · Granted Nov 10, 2009 · Expires Nov 5, 2029

    granted
  17. US 7615223

    Selected immunoconjugates for binding to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 10, 2009 · Expires Nov 5, 2029

    granted
  18. US 7611693

    Mechanism-based targeted pancreatic beta cell imaging and therapy

    The Board of Regents of the University of Texas System · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  19. US 7611704

    Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Nov 3, 2009 · Expires Oct 29, 2029

    granted
  20. US 7601683

    Protein conformational isomers, methods of making, methods for using, compositions comprising and products made therewith

    The Board of Regents of the University of Texas System · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  21. US 7601490

    Development of influenza A antivirals

    The Board of Regents of the University of Texas System · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  22. US 7601731

    Antimicrobial flush solutions

    The Board of Regents of the University of Texas System · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  23. US 7582281

    Ethylenedicysteine (EC)-drug conjugates compositions and methods for tissue specific disease imaging

    The Board of Regents of the University of Texas System · Granted Sep 1, 2009 · Expires Aug 27, 2029

    granted
  24. US 7579014

    Mesoporous compositions for use in drug delivery

    The Board of Regents of the University of Texas System · Granted Aug 25, 2009 · Expires Aug 20, 2029

    granted